ERCC1 and head and neck squamous cell carcinoma: Moreover, gene expression analysis of pretreatment biopsy specimens from 64 HNSCC patients treated with 5−FU/cisplatin identified that ERCC1 expression is a significant predictor of response to chemotherapy, further indicating that DNA repair is a pivotal mechanism implicated in response to chemotherapy in HNSCC (22).